P. Riekkinen et al., EFFECTS OF NICOTINE ON NEOCORTICAL ELECTRICAL-ACTIVITY IN RATS, The Journal of pharmacology and experimental therapeutics, 267(2), 1993, pp. 776-784
The present study investigates the effects of acute and repeated nicot
ine i.p. treatment on cortical EEG activity. Nicotine at 0.3 and 0.9 m
g/kg, but not at 0.1 mg/kg, decreased high voltage spindles (HVSs). Ni
cotine at 2.7 mg/kg suppressed HVSs completely. Mecamylamine, a nicoti
nic cholinergic antagonist, increased HVSs at 5 and 7.5 mg/kg. Nicotin
e blocked the HVS induction induced by mecamylamine. Mecamylamine at 1
.25 mg/kg antagonized the HVS suppressing action of nicotine at 0.3 mg
/kg. The muscarinic cholinergic antagonist, scopolamine (0.2 mg/kg), i
ncreased the 1 to 20 Hz amplitude sum value, and this increase was blo
cked to some extent by the highest dose of nicotine (2.7 mg/kg). Howev
er, nicotine did not block the effect of a higher scopolamine (2.0 mg/
kg) dose on the sum amplitude values. Mecamylamine at 2.5 and 7.5 mg/k
g blocked the effect of nicotine at 2.7 mg/kg on the EEG sum amplitude
values in scopolamine (0.2 mg/kg)-treated rats. The peripherally acti
ng nicotinic and muscarinic cholinergic antagonists, hexamethonium and
scopolamine methylbromide, had no effect on spectral EEG and HVS valu
es. In quisqualic acid nucleus basalis-lesioned rats, a frontal cortic
al choline acetyltransferase depletion (-72%) and slowing of the EEG w
as observed. Nicotine could not restore EEG activity in nucleus basali
s-lesioned rats. After repeated (10 days, three injections/day) admini
stration of nicotine, no tolerance to the effects of either nicotine (
0.9 mg/kg) on spontaneously occuring HVSs or nicotine (2.7 mg/kg) on t
he EEG change induced by scopolamine was observed. The present results
show that nicotinic receptor stimulation desynchronizes neocortical E
EG activity in normal animals, but this action disappears in basal for
ebrain-lesioned animals. Therefore, it is likely that the effects of n
icotine in reversing EEG and behavioral abnormalities observed in Alzh
eimer's disease may be limited if the basal forebrain cell loss is ext
ensive.